ORASURE TECHNOLOGIES, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 0.00 shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 2.00K shares, a 81.82% decline year-over-year.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 32.00K shares, a 27.27% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 44.00K shares, a 2100.00% increase from fiscal 2022.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 2.00K shares, a 93.94% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-09 | |
| 2024-12-31 | 32.00K shares 10-K · filed 2025-03-07 | |
| 2023-12-31 | 44.00K shares 10-K · filed 2024-03-11 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | 2.00K shares 10-K · filed 2023-03-03 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | |
| 2022-03-31 | 2.00K shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 33.00K shares 10-K · filed 2022-03-01 | |
| 2021-03-31 | 11.00K shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 402.00K shares 10-K · filed 2021-03-01 | |
| 2020-03-31 | 6.00K shares 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 27.00K shares 10-K · filed 2020-03-02 | |
| 2019-03-31 | 4.00K shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 227.00K shares 10-K · filed 2019-02-28 | |
| 2018-03-31 | 133.00K shares 10-Q · filed 2018-05-09 | |
| 2017-12-31 | 4.41M shares 10-K · filed 2018-02-28 | |
| 2017-03-31 | 1.46M shares 10-Q · filed 2017-05-09 | |
| 2016-12-31 | 405.00K shares 10-K · filed 2018-02-28 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 74.00K shares 10-K · filed 2018-02-28 | |
| 2015-03-31 | 74.00K shares 10-Q · filed 2015-05-08 | |
| 2014-12-31 | 249.00K shares 10-K · filed 2017-03-14 | |
| 2014-03-31 | 22.00K shares 10-Q · filed 2014-05-08 | |
| 2013-12-31 | 80.00K shares 10-K · filed 2016-03-14 | |
| 2013-03-31 | 49.00K shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 1.48M shares 10-K · filed 2015-03-12 | |
| 2011-12-31 | 880.00K shares 10-K · filed 2014-03-14 | |
| 2010-12-31 | 3.00K shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |